On Demand Webinar

Are You Choosing the Right Model? A Guide to Selecting Your Next Immuno-Oncology Model

Presented by Dr. Michelle Mack, Global Director, Scientific Engagement, Crown Bioscience Inc.

Determining the best experimental immunotherapy model is a major obstacle toward developing better treatments. New models with different capabilities are constantly being developed, so choosing the right preclinical model is critical.

In this webinar, Dr. Mack will outline the latest in vivo cancer pharmacology models, and highlight some key considerations when beginning the selection process for your next immuno-oncology model.

This presentation highlights how critical choosing the correct and relevant preclinical model is critical, particularly to recapitulate clinical treatments including combination therapies, as new models are developed, with different capabilities, at a feverish pace.

Watch This Webinar To Learn:

• The latest in vivo cancer pharmacology models

• Factors to consider when choosing the proper model

• How these models are used to investigate combination regimens of multiple immuno-therapies and immunotherapeutics combined with other treatment modalities, and more.

Watch The Webinar Now!

About The Presenter:

Dr. Michelle Mack is Global Director of Scientific Engagement at Crown Bioscience Inc. She is a molecular biologist with over 15 years of experience in drug discovery and development in large pharmaceutical companies. Prior to joining CrownBio, Dr. Mack was a Senior Scientist in the Oncology Research Unit and served as a research project leader on oncology therapeutic programs.